{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:49:39Z","timestamp":1792651779949,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,11,22]],"date-time":"2010-11-22T00:00:00Z","timestamp":1290384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2010,11,22]],"date-time":"2010-11-22T00:00:00Z","timestamp":1290384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1038\/cmi.2010.56","type":"journal-article","created":{"date-parts":[[2011,1,4]],"date-time":"2011-01-04T07:24:03Z","timestamp":1294125843000},"page":"59-66","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":227,"title":["A reversed CD4\/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4+FOXP3+ regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix"],"prefix":"10.1038","volume":"8","author":[{"given":"Walayat","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,11,22]]},"reference":[{"key":"BFcmi201056_CR1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/BF00210630","volume":"74","author":"V Umansky","year":"1996","unstructured":"Umansky V, Schirrmacher V, Rocha M . New insights into tumor-host interactions in lymphoma metastasis. J Mol Med 1996; 74: 353\u2013363.","journal-title":"J Mol Med"},{"key":"BFcmi201056_CR2","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S0140-6736(09)60404-9","volume":"373","author":"ML Disis","year":"2009","unstructured":"Disis ML, Bernhard H, Jaffee EM . Use of tumour-responsive T cells as cancer treatment. Lancet 2009; 373: 673\u2013683.","journal-title":"Lancet"},{"key":"BFcmi201056_CR3","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.athoracsur.2008.10.067","volume":"87","author":"E Ruffini","year":"2009","unstructured":"Ruffini E, Asioli S, Filosso PL, Lyberis P, Bruna MC et al. Clinical significance of tumor-infiltrating lymphocytes in lung neoplasms. Ann Thorac Surg 2009; 87: 365\u2013371.","journal-title":"Ann Thorac Surg"},{"key":"BFcmi201056_CR4","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00262-008-0583-5","volume":"58","author":"N Leffers","year":"2009","unstructured":"Leffers N, Gooden MJ, de Jong RA, Hoogeboom BN, ten Hoor KA, Hollema H et al. Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer. Cancer Immunol Immunother 2009; 58: 449\u2013459.","journal-title":"Cancer Immunol Immunother"},{"key":"BFcmi201056_CR5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ygyno.2007.10.016","volume":"108","author":"M Tomsova","year":"2008","unstructured":"Tomsova M, Melichar B, Sedlakova I, Steiner I . Prognostic significance of CD3+ tumor infiltrating lymphocytes in ovarian carcinoma. Gynecol Oncol 2008; 108: 415\u2013420.","journal-title":"Gynecol Oncol"},{"key":"BFcmi201056_CR6","first-page":"12","volume":"7","author":"GP Dunn","year":"2007","unstructured":"Dunn GP, Dunn IF, Curry WT . Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human glioma. Cancer Immun. 2007; 7: 12.","journal-title":"Cancer Immun"},{"key":"BFcmi201056_CR7","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1126\/science.313.5795.1868b","volume":"313","author":"J Couzin","year":"2006","unstructured":"Couzin J . Cancer. T cells a boon for colon cancer prognosis. Science 2006; 313: 1868\u20131869.","journal-title":"Science"},{"key":"BFcmi201056_CR8","doi-asserted-by":"publisher","first-page":"18538","DOI":"10.1073\/pnas.0509182102","volume":"102","author":"E Sato","year":"2005","unstructured":"Sato E, Olson SH, Ahn J, Bundy B, Nishikawa H, Qian F et al. Intraepithelial CD8+ tumor infiltrating lymphocytes and a high CD8+\/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci USA 2005; 102: 18538\u201318543.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcmi201056_CR9","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.humpath.2004.01.022","volume":"35","author":"F Prall","year":"2004","unstructured":"Prall F, Duhrkop T, Weirich V, Ostwald C, Lenz P, Nizze H et al. Prognostic role of CD8+ tumor-infiltrating lymphocytes in stage III colorectal cancer with and without microsatellite instability. Hum Pathol 2004; 35: 808\u2013816.","journal-title":"Hum Pathol"},{"key":"BFcmi201056_CR10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/00006676-200401000-00023","volume":"28","author":"A Fukunaga","year":"2004","unstructured":"Fukunaga A, Miyamoto M, Cho Y, Murakami S, Kawarada Y, Oshikiri T et al. CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma. Pancreas 2004; 28: 26\u201331.","journal-title":"Pancreas"},{"key":"BFcmi201056_CR11","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/S0952-7915(98)80228-8","volume":"10","author":"DM Pardoll","year":"1998","unstructured":"Pardoll DM, Topalian SL . The role of CD4+ T cell responses in antitumor immunity. Curr Opin Immunol 1998; 10: 588\u2013594.","journal-title":"Curr Opin Immunol"},{"key":"BFcmi201056_CR12","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1084\/jem.189.5.753","volume":"189","author":"RE Toes","year":"1999","unstructured":"Toes RE, Ossendorp F, Offringa R, Melief CJ . CD4 T cells and their role in antitumor immune responses. J Exp Med 1999; 189: 753\u2013756.","journal-title":"J Exp Med"},{"key":"BFcmi201056_CR13","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1172\/JCI0217214","volume":"110","author":"WY Ho","year":"2002","unstructured":"Ho WY, Yee C, Greenberg PD . Adoptive therapy with CD8+ T cells: it may get by with a little help from its friends. J Clin Invest 2002; 110: 1415\u20131417.","journal-title":"J Clin Invest"},{"key":"BFcmi201056_CR14","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nri1413","volume":"4","author":"MJ Bevan","year":"2004","unstructured":"Bevan MJ . Helping the CD8+ T-cell response. Nat Rev Immunol 2004; 4: 595\u2013602.","journal-title":"Nat Rev Immunol"},{"key":"BFcmi201056_CR15","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.1076514","volume":"19","author":"ME Dudley","year":"2002","unstructured":"Dudley ME, Wunderlich JR, Robbins PF, Yang JC, Hwu P, Schwartzentruber DJ et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 2002; 19: 850\u2013854.","journal-title":"Science"},{"key":"BFcmi201056_CR16","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1136\/gut.2008.175521","volume":"58","author":"I Sobhani","year":"2009","unstructured":"Sobhani I, Le Gouvello S . Critical role for CD8+FoxP3+ regulatory T cells in colon cancer immune response in humans. Gut 2009; 58: 743\u2013744.","journal-title":"Gut"},{"key":"BFcmi201056_CR17","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1200\/JCO.2008.18.7229","volume":"27","author":"P Salama","year":"2009","unstructured":"Salama P, Phillips M, Grieu F, Morris M, Zeps N, Joseph D et al. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol 2009; 27: 186\u2013192.","journal-title":"J Clin Oncol"},{"key":"BFcmi201056_CR18","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1038\/sj.leu.2404913","volume":"21","author":"LM Gjerdrum","year":"2007","unstructured":"Gjerdrum LM, Woetmann A, Odum N, Burton CM, Rossen K, Skovgaard GL et al. FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival. Leukemia 2007; 21: 2512\u20132518.","journal-title":"Leukemia"},{"key":"BFcmi201056_CR19","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1053\/j.gastro.2007.03.102","volume":"132","author":"J Fu","year":"2007","unstructured":"Fu J, Xu D, Liu Z, Shi M, Zhao P, Fu B et al. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology 2007; 132: 2328\u20132339.","journal-title":"Gastroenterology"},{"key":"BFcmi201056_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/labinvest.3700389","volume":"86","author":"P Yu","year":"2006","unstructured":"Yu P, Fu YX . Tumor-infiltrating T lymphocytes: friends or foes? Lab Invest 2006; 86: 231\u2013245.","journal-title":"Lab Invest"},{"key":"BFcmi201056_CR21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ejso.2007.08.008","volume":"34","author":"A Sasaki","year":"2008","unstructured":"Sasaki A, Tanaka F, Mimori K, Inoue H, Kai S, Shibata K et al. Prognostic value of tumor-infiltrating FOXP3+ regulatory T cells in patients with hepatocellular carcinoma. Eur J Surg Oncol 2008; 34: 173\u2013179.","journal-title":"Eur J Surg Oncol"},{"key":"BFcmi201056_CR22","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1038\/sj.bjc.6604294","volume":"98","author":"T Yoshioka","year":"2008","unstructured":"Yoshioka T, Miyamoto M, Cho Y, Ishikawa K, Tsuchikawa T, Kadoya M et al. Infiltrating regulatory T cell numbers is not a factor to predict patient's survival in oesophageal squamous cell carcinoma. Br J Cancer 2008; 98: 1258\u20131263.","journal-title":"Br J Cancer"},{"key":"BFcmi201056_CR23","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/10428190701824536","volume":"49","author":"NR Lee","year":"2008","unstructured":"Lee NR, Song EK, Jang KY, Choi HN, Moon WS, Kwon K et al. Prognostic impact of tumor infiltrating FOXP3 positive regulatory T cells in diffuse large B-cell lymphoma at diagnosis. Leuk Lymphoma 2008; 49: 247\u2013256.","journal-title":"Leuk Lymphoma"},{"key":"BFcmi201056_CR24","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1158\/1078-0432.CCR-05-2434","volume":"12","author":"GG Grabenbauer","year":"2006","unstructured":"Grabenbauer GG, Lahmer G, Distel L, Niedobitek G . Tumor-infiltrating cytotoxic T cells but not regulatory T cells predict outcome in anal squamous cell carcinoma. Clin Cancer Res 2006; 12: 3355\u20133360.","journal-title":"Clin Cancer Res"},{"key":"BFcmi201056_CR25","first-page":"123","volume":"3","author":"W Yan","year":"2006","unstructured":"Yan W, Le Z, Hongyan W, Juxiang X, Lusheng S, Yili W . The ex vivo microenvironments in MLTC of poorly immunogenic tumor cells facilitate polarization of CD4+CD25+ regulatory T cells. Cell Mol Immunol 2006; 3: 123\u2013129.","journal-title":"Cell Mol Immunol"},{"key":"BFcmi201056_CR26","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/GCO.0b013e32831a9890","volume":"21","author":"S Patel","year":"2009","unstructured":"Patel S, Chiplunkar S . Host immune responses to cervical cancer. Curr Opin Obstet Gyneco 2009; 21: 54\u201359.","journal-title":"Curr Opin Obstet Gyneco"},{"key":"BFcmi201056_CR27","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1111\/j.1349-7006.2009.01153.x","volume":"100","author":"C Loddenkemper","year":"2009","unstructured":"Loddenkemper C, Hoffmann C, Stanke J, Nagorsen D, Baron U, Olek S et al. Regulatory (FOXP3+) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer. Cancer Sci 2009; 100: 1112\u20131117.","journal-title":"Cancer Sci"},{"key":"BFcmi201056_CR28","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1093\/jnci\/87.11.796","volume":"87","author":"FX Bosch","year":"1995","unstructured":"Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995; 87: 796\u2013802.","journal-title":"J Natl Cancer Inst"},{"key":"BFcmi201056_CR29","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Munoz","year":"2003","unstructured":"Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsagu\u00e9 X, Shah KV et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518\u2013527.","journal-title":"N Engl J Med"},{"key":"BFcmi201056_CR30","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.clon.2009.09.003","volume":"21","author":"W Shah","year":"2009","unstructured":"Shah W, Hongwei C, Jin Z, Lifang D, Jun Y, Yili W . The prevalence of human papillomavirus type 58 in Chinese patients with cervical carcinoma and its influence on survival. Clin Oncol (R Coll Radiol). 2009; 21: 768\u2013774.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"BFcmi201056_CR31","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1158\/0008-5472.CAN-06-3388","volume":"67","author":"SJ Piersma","year":"2007","unstructured":"Piersma SJ, Jordanova ES, van Poelgeest MI, Kwappenberg KM, van der Hulst JM, Drijfhout JW et al. High Number of Intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer. Cancer Res 2007; 67: 354\u2013361.","journal-title":"Cancer Res"},{"key":"BFcmi201056_CR32","doi-asserted-by":"publisher","first-page":"4450","DOI":"10.1158\/1078-0432.CCR-0732-3","volume":"10","author":"S Kondratiev","year":"2004","unstructured":"Kondratiev S, Sabo E, Yakirevich E, Lavie O, Resnick MB . Resnick. Intratumoral CD8+ T lymphocytes as a prognostic factor of survival in endometrial carcinoma. Clin Cancer Res 2004; 10: 4450\u20134456.","journal-title":"Clin Cancer Res"},{"key":"BFcmi201056_CR33","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1038\/sj.bjc.6602201","volume":"91","author":"T Chiba","year":"2004","unstructured":"Chiba T, Ohtani H, Mizoi T, Naito Y, Sato E, Nagura H et al. Intraepithelial CD8+ T-cell-count becomes a prognostic factor after a longer follow-up period in human colorectal carcinoma: possible association with suppression of micrometastasis. Br J Cancer 2004; 91: 1711\u20131717.","journal-title":"Br J Cancer"},{"key":"BFcmi201056_CR34","first-page":"3932","volume":"61","author":"K Schumacher","year":"2001","unstructured":"Schumacher K, Haensch W, Roefzaad C, Schlag PM . Prognostic significance of activated CD8+ T cell infiltrations within esophageal carcinomas. Cancer Res 2001; 61: 3932\u20133936.","journal-title":"Cancer Res"},{"key":"BFcmi201056_CR35","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.1073\/pnas.0611618104","volume":"104","author":"P Sharma","year":"2007","unstructured":"Sharma P, Shen Y, Wen S, Yamada S, Jungbluth AA, Gnjatic S et al. CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma. Proc Natl Acad Sci USA 2007; 104: 3967\u20133972.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcmi201056_CR36","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1111\/j.1349-7006.2003.tb01392.x","volume":"94","author":"O Wakabayashi","year":"2003","unstructured":"Wakabayashi O, Yamazaki K, Oizumi S, Hommura F, Kinoshita I, Ogura S et al. CD4+ T cells in cancer stroma, not CD8+ T cells in cancer cell nests, are associated with favorable prognosis in human non-small cell lung cancers. Cancer Sci 2003; 94: 1003\u20131009.","journal-title":"Cancer Sci"},{"key":"BFcmi201056_CR37","first-page":"5132","volume":"61","author":"O Nakano","year":"2001","unstructured":"Nakano O, Sato M, Naito Y, Suzuki K, Orikasa S, Aizawa M et al. Proliferative activity of intratumoral CD8+ T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity. Cancer Res 2001; 61: 5132\u20135136.","journal-title":"Cancer Res"},{"key":"BFcmi201056_CR38","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ygyno.2005.11.039","volume":"102","author":"S Monnier-Benoit","year":"2006","unstructured":"Monnier-Benoit S, Mauny F, Riethmuller D, Guerrini JS, C\u0103p\u00eelna M, F\u00e9lix S et al. Immunohistochemical analysis of CD4+ and CD8+ T-cell subsets in high risk human papillomavirus-associated pre-malignant and malignant lesions of the uterine cervix. Gynecol Oncol 2006; 102: 22\u201331.","journal-title":"Gynecol Oncol"},{"key":"BFcmi201056_CR39","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0090-8258(03)00083-0","volume":"89","author":"AD Santin","year":"2003","unstructured":"Santin AD, Bellone S, Palmieri M, Bossini B, Roman JJ, Cannon MJ et al. Induction of tumor-specific cytotoxicity in tumor infiltrating lymphocytes by HPV16 and HPV18 E7-pulsed autologous dendritic cells in patients with cancer of the uterine cervix. Gynecol Oncol 2003; 89: 271\u2013280.","journal-title":"Gynecol Oncol"},{"key":"BFcmi201056_CR40","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/nri1434","volume":"4","author":"M Baniyash","year":"2004","unstructured":"Baniyash M . TCR \u03b6-chain down regulation: curtailing an excessive inflammatory immune response. Nat Rev Immunol 2004; 4: 675\u2013687.","journal-title":"Nat Rev Immunol"},{"key":"BFcmi201056_CR41","first-page":"384","volume":"38","author":"HY Wang","year":"2009","unstructured":"Wang HY, He JJ, Shi QF, Lai BC, Ding HY, Zheng J et al. Clinicopathological significance of cytotoxic lymphocytes in breast cancer and draining lymph nodes. Zhonghua Bing Li Xue Za Zhi. 2009; 38: 384\u2013388. Chinese.","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"BFcmi201056_CR42","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/sj.bjc.6604001","volume":"97","author":"BS Nedergaard","year":"2007","unstructured":"Nedergaard BS, Ladekarl M, Thomsen HF, Nyengaard JR, Nielsen K . Low density of CD3+, CD4+ and CD8+ cells is associated with increased risk of relapse in squamous cell cervical cancer. Br J Cancer 2007; 97: 1135\u20131138.","journal-title":"Br J Cancer"},{"key":"BFcmi201056_CR43","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1158\/1078-0432.CCR-05-1886","volume":"12","author":"C Badoual","year":"2006","unstructured":"Badoual C, Hans S, Rodriguez J, Peyrard S, Klein C, Agueznay Nel H et al. Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers. Clin Cancer Res 2006; 12: 465\u2013472.","journal-title":"Clin Cancer Res"},{"key":"BFcmi201056_CR44","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.immunol.21.120601.141122","volume":"22","author":"S Sakaguchi","year":"2004","unstructured":"Sakaguchi S . Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004; 22: 531\u2013562.","journal-title":"Annu Rev Immunol"},{"key":"BFcmi201056_CR45","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.smim.2003.12.005","volume":"16","author":"C Baecher-Allan","year":"2004","unstructured":"Baecher-Allan C, Viglietta V, Hafler DA . Human CD4+CD25+ regulatory T cells. Semin Immunol 2004; 16: 89\u201398.","journal-title":"Semin Immunol"},{"key":"BFcmi201056_CR46","first-page":"3128","volume":"59","author":"S Onizuka","year":"1999","unstructured":"Onizuka S, Tawara I, Shimizu J, Sakaguchi S, Fujita T, Nakayama E . Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor) monoclonal antibody. Cancer Res 1999; 59: 3128\u20133133","journal-title":"Cancer Res"},{"key":"BFcmi201056_CR47","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.4049\/jimmunol.163.10.5211","volume":"163","author":"J Shimizu","year":"1999","unstructured":"Shimizu J, Yamazaki S, Sakaguchi S . Induction of tumor immunityby removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J Immunol 1999; 163: 5211\u20135218.","journal-title":"J Immunol"},{"key":"BFcmi201056_CR48","doi-asserted-by":"publisher","first-page":"9253","DOI":"10.1073\/pnas.0503852102","volume":"102","author":"H Nishikawa","year":"2005","unstructured":"Nishikawa H, Kato T, Tawara I, Takemitsu T, Saito K, Wang L et al. Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts. Proc Natl Acad Sci USA 2005; 102: 9253\u20139257.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcmi201056_CR49","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1084\/jem.194.6.823","volume":"194","author":"RP Sutmuller","year":"2001","unstructured":"Sutmuller RP, van Duivenvoorde LM, van Elsas A, Schumacher TN, Wildenberg ME, Allison JP et al. Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25+ regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J Exp Med 2001; 194: 823\u2013832.","journal-title":"J Exp Med"},{"key":"BFcmi201056_CR50","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/00002371-200205000-00003","volume":"25","author":"H Tanaka","year":"2002","unstructured":"Tanaka H, Tanaka J, Kjaergaard J, Shu S . Depletion of CD4+CD25+ regulatory cells augments the generation of specific immune T cells in tumor-draining lymph nodes. J Immunother 2002; 25: 207\u2013217.","journal-title":"J Immunother"},{"key":"BFcmi201056_CR51","doi-asserted-by":"publisher","first-page":"12087","DOI":"10.1073\/pnas.0704672104","volume":"104","author":"SH van der Burg","year":"2007","unstructured":"van der Burg SH, Piersma SJ, de Jong A, van der Hulst JM, Kwappenberg KM, van den Hende M et al. Association of cervical cancer with the presence of CD4+ regulatory T cells specific for human papillomavirus antigens. Proc Natl Acad Sci USA 2007; 104: 12087\u201312092.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcmi201056_CR52","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1002\/(SICI)1097-0142(19991015)86:8<1537::AID-CNCR21>3.0.CO;2-D","volume":"86","author":"BC Sheu","year":"1999","unstructured":"Sheu BC, Hsu SM, Ho HN, Lin RH, Torng PL, Huang SC . Reversed CD4\/CD8 ratios of tumor-infiltrating lymphocytes are correlated with the progression of human cervical carcinoma. Cancer 1999; 86: 1537\u20131543.","journal-title":"Cancer"},{"key":"BFcmi201056_CR53","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/0167-5699(93)90262-J","volume":"14","author":"L Chen","year":"1993","unstructured":"Chen L, Linsley PS, Hellstr\u00f6m KE . Costimulation of T cells for tumor immunity. Immunol Today 1993; 14: 483\u2013486.","journal-title":"Immunol Today"},{"key":"BFcmi201056_CR54","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1093\/intimm\/10.10.1397","volume":"10","author":"TY Cheng","year":"1998","unstructured":"Cheng TY, Wu JT, Lin RH . Induction of tumor-specific T cell response by cognating tumor cells with foreign antigen-primed Th cells. Int Immunol 1998; 10: 1397\u20131406.","journal-title":"Int Immunol"},{"key":"BFcmi201056_CR55","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0065-2776(08)60778-6","volume":"49","author":"PD Greenberg","year":"1991","unstructured":"Greenberg PD . Adoptive T cells therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells. Adv Immunol 1991; 49: 281\u2013355.","journal-title":"Adv Immunol"},{"key":"BFcmi201056_CR56","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1084\/jem.181.2.619","volume":"181","author":"S Baskar","year":"1995","unstructured":"Baskar S, Glimcher L, Nabavi N, Jones RT, Ostrand-Rosenberg S . Major histocompatibility complex II1B7211 tumor cells are potent vaccines for stimulating tumor rejection on tumor-bearing mice. J Exp Med 1995; 181: 619\u2013629.","journal-title":"J Exp Med"},{"key":"BFcmi201056_CR57","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jhep.2005.12.027","volume":"45","author":"E Unitt","year":"2006","unstructured":"Unitt E, Marshall A, Gelson W, Rushbrook SM, Davies S, Vowler S et al. Tumour lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation. J Hepatol 2006; 45: 246\u2013253.","journal-title":"J Hepatol"}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cmi201056.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cmi201056","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cmi201056.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T10:14:43Z","timestamp":1672740883000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cmi201056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,22]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["BFcmi201056"],"URL":"https:\/\/doi.org\/10.1038\/cmi.2010.56","relation":{},"ISSN":["1672-7681","2042-0226"],"issn-type":[{"value":"1672-7681","type":"print"},{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,22]]},"assertion":[{"value":"9 April 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}